New drug aimed at stubborn hives enters key trials
NCT ID NCT07378527
First seen Jan 31, 2026 · Last updated Jun 22, 2026 · Updated 23 times
Summary
This study tests a new medication called ICP-332 for people with moderate to severe chronic spontaneous urticaria (hives) that aren't controlled by standard antihistamines. About 344 adults will receive either the drug or a placebo for up to 24 weeks. The main goal is to see if it reduces itching and hives better than placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC SPONTANEOUS URTICARIA (CSU) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University
NOT_YET_RECRUITINGHangzhou, Zhejiang, China
Contact
-
Affiliated Hospital of Jiangsu University
NOT_YET_RECRUITINGZhenjiang, Jiangsu, 210031, China
Contact
-
Beijing Tongren Hospital, Capital Medical University
NOT_YET_RECRUITINGBeijing, Beijing Municipality, 100730, China
Contact
-
Bengbu Medical University First Affiliated Hospital
NOT_YET_RECRUITINGBengbu, Anhui, 233004, China
Contact
-
Chengdu Second People's Hospital
NOT_YET_RECRUITINGChengdu, Sichuan, 610017, China
Contact
-
Chongqing Traditional Chinese Medicine Hospital
NOT_YET_RECRUITINGChongqing, Chongqing Municipality, 400021, China
Contact
-
Dermatology Hospital of Southern Medical University
NOT_YET_RECRUITINGGuangzhou, Guangdong, 510091, China
Contact
-
First Affiliated Hospital of Fujian Medical University
NOT_YET_RECRUITINGFuzhou, Fujian, 350005, China
Contact
-
First Hospital of Shanxi Medical University
NOT_YET_RECRUITINGTaiyuan, Shanxi, 030001, China
Contact
-
Hangzhou Third People's Hospital
NOT_YET_RECRUITINGHangzhou, Zhejiang, 310009, China
Contact
-
Henan Provincial People's Hospital
NOT_YET_RECRUITINGZhengzhou, Henan, 450003, China
Contact
-
Jinan Central Hospital
NOT_YET_RECRUITINGJinan, Shandong, 250013, China
Contact Email: •••••@•••••
-
Jingzhou Central Hospital
NOT_YET_RECRUITINGJingzhou, Hubei, 434020, China
Contact
-
Peking University People's Hospital
RECRUITINGBeijing, Beijing Municipality, 100044, China
Contact
Contact
-
Shandong Provincial Hospital for Skin Disease, Shandong First Medical University
NOT_YET_RECRUITINGJinan, Shandong, 250022, China
Contact
-
Shanghai Skin Disease Hospital
NOT_YET_RECRUITINGShanghai, Shanghai Municipality, 200443, China
Contact
-
Shenyang Hospital of Integrated Traditional Chinese and Western Medicine （Shenyang Seventh People's Hospital）
NOT_YET_RECRUITINGShenyang, Liaoning, 110001, China
Contact
-
Shiyan Taihe Hospital
NOT_YET_RECRUITINGShiyan, Hubei, 442000, China
Contact
-
Sichuan Academy of Medical Sciences&Sichuan Provincial People's Hospital
NOT_YET_RECRUITINGChengdu, Sichuan, 610072, China
Contact
-
Suzhou Municipal Hospital
NOT_YET_RECRUITINGSuzhou, Jiangsu, 215002, China
Contact
-
The First Affiliated Hospital of Chongqing Medical University
NOT_YET_RECRUITINGChongqing, Chongqing Municipality, 400016, China
Contact
-
The First Affiliated Hospital of Kunming Medical University
NOT_YET_RECRUITINGKunming, Yunnan, 650032, China
Contact
-
The First Affiliated Hospital of Xi'an Jiaotong University
NOT_YET_RECRUITINGXi'an, Shaanxi, 710061, China
Contact
-
The First Hospital of Jilin University
NOT_YET_RECRUITINGChangchun, Jilin, 130021, China
Contact
-
The Second Affiliated Hospital of Henan University of Science and Technology
NOT_YET_RECRUITINGLuoyang, Henan, China
Contact
-
The Second Affiliated Hospital of Wannan Medical College
NOT_YET_RECRUITINGWuhu, Anhui, 241000, China
Contact
-
The Second Hospital of Hebei Medical University
NOT_YET_RECRUITINGShijiazhuang, Hebei, 050000, China
Contact
-
Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital
NOT_YET_RECRUITINGTianjin, Tianjin Municipality, 300131, China
Contact
Contact
-
Wuxi No. 2 People's Hospital
NOT_YET_RECRUITINGWuxi, Jiangsu, 214001, China
Contact
-
Xiangya hospital central south university
NOT_YET_RECRUITINGChangsha, Hunan, 410008, China
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ICP-332 tablets
What this could lead to
If successful, this could provide a new oral treatment option for people with chronic hives that don't respond well to standard antihistamines.
What could go wrong
This is an early-to-mid stage trial (Phase 2/3), so the drug may not prove effective or safe enough for approval. Side effects are still being studied.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.